` CHRCF (Chrysos Corporation Ltd) vs S&P 500 Comparison - Alpha Spread

C
CHRCF
vs
S&P 500

Over the past 12 months, CHRCF has significantly outperformed S&P 500, delivering a return of +88% compared to the S&P 500's +13% growth.

Stocks Performance
CHRCF vs S&P 500

Loading
CHRCF
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CHRCF vs S&P 500

Loading
CHRCF
S&P 500
Difference
www.alphaspread.com

Performance By Year
CHRCF vs S&P 500

Loading
CHRCF
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Chrysos Corporation Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Chrysos Corporation Ltd
Glance View

Market Cap
713.2m USD
Industry
Professional Services

Chrysos Corp. Ltd. engages in providing novel assay services to the global mining industry through its proprietary Chrysos PhotonAssay technology. The company is headquartered in Adelaide, South Australia and currently employs 163 full-time employees. The company went IPO on 2022-05-06. The firm has three reportable segments: EMEA, Australia and Americas. The firm's flagship product, PhotonAssay, delivers environmentally friendly analysis of gold, silver, copper and other elements. PhotonAssay is an environmentally friendly replacement for fire assay on-site and in the laboratory. PhotonAssay can be used to detect a range of elements, the technology has proven particularly effective for assaying gold and is being rolled out across the gold mining industry. PhotonAssay units are deployed to mine sites and independent laboratories which provide assay services. PhotonAssay technology, hitting samples with high-energy X-rays, causes excitation of atomic nuclei allowing enhanced analysis of elements in approximately two minutes. The firm has operations spanning Australia, Africa, North America and Europe.

CHRCF Intrinsic Value
3.38 USD
Overvaluation 45%
Intrinsic Value
Price
C
Back to Top